Organ Manifestation and Systematic Organ Screening at the Onset of Inflammatory Rheumatic Diseases

Medientyp: E-Artikel

Titel: Organ Manifestation and Systematic Organ Screening at the Onset of Inflammatory Rheumatic Diseases

Beteiligte: Hoffmann, Tobias [VerfasserIn]; Oelzner, Peter [VerfasserIn]; Busch, Martin [VerfasserIn]; Franz, Marcus [VerfasserIn]; Teichgräber, Ulf [VerfasserIn]; Kroegel, Claus [VerfasserIn]; Schulze, Paul Christian [VerfasserIn]; Wolf, Gunter [VerfasserIn]; Pfeil, Alexander [VerfasserIn]

Erschienen: 29 December 2021

Sprache: Englisch

DOI: 10.3390/diagnostics12010067

ISSN: 2075-4418

Identifikator:

Entstehung:

Anmerkungen:

Beschreibung: Abstract: Background: Inflammatory rheumatic diseases (IRD) are often associated with the involvement of various organs. However, data regarding organ manifestation and organ spread are rare. To close this knowledge gap, this cross-sectional study was initiated to evaluate the extent of solid organ manifestations in newly diagnosed IRD patients, and to present a structured systematic organ screening algorithm. Materials and Methods: The study included 84 patients (63 women, 21 men) with newly diagnosed IRD. None of the patients received any rheumatic therapy. All patients underwent a standardised organ screening programme encompassing a basic screening (including lungs, heart, kidneys, and gastrointestinal tract) and an additional systematic screening (nose and throat, central and peripheral nervous system) on the basis of clinical, laboratory, and immunological findings. Results: Represented were patients with connective tissue diseases (CTD) (72.6%), small-vessel vasculitis (16.7%), and myositis (10.7%). In total, 39 participants (46.5%) had one or more organ manifestation(s) (one organ, 29.7%; two organs, 10.7%; ≥three organs, 6.0%). The most frequently involved organs were the lungs (34.5%), heart (11.9%), and kidneys (8.3%). Lastly, a diagnostic algorithm for organ manifestation was applied. Conclusion: One-half of the patients presented with a solid organ involvement at initial diagnosis of IRD. Thus, in contrast to what has been described in the literature, organ manifestations were already present in a high proportion of patients at the time of diagnosis of IRD rather than after several years of disease. Therefore, in IRD patients, systematic organ screening is essential for treatment decisions. Keywords: inflammatory rheumatic diseases; IRD; connective tissue diseases; newly diagnosed; organ involvement; organ screening

Zugangsstatus: Freier Zugang

Nur in Feld suchen:

Zuletzt gesuchte Begriffe: